http://www.fpnotebook.com/
Intranasal SteroidAka: Corticosteroid Intranasal, Nasacort, Rhinocort, Nasarel, Beconase, Vancenase, Flonase
- Efficacy of Intranasal Steroids
- Significantly reduced symptoms
- Reduced nasal obstruction
- Reduced Rhinorrhea, sneezing, and nasal itching
- By comparison, Seldane was same as Placebo
- Reference
- Significantly reduced symptoms
- Safety
- Appears safe in children as young as age 2 years
- No hypothalamic-pituitary-adrenal axis suppression
- Galant (2003) Pediatrics 112:96
- Appears safe in children as young as age 2 years
- Adverse Effects
- Epistaxis
- Reduced by spraying away from septum
- Use left hand when spraying right nostril
- Use right hand when spraying left nostril
- (2004) Prescribers Letter 11(1):2
- Epistaxis
- General
- Aqueous Preparations: Better for dry nose, winter
- Moisturizing: Nasarel (Flunisolide)
- Moisture neutral: Nasocort AQ and Rhinocort AQ
- Drying agents (Alcohol): most AQ agents
- Non-Aqueous: Better for "wet", watery nose
- Aqueous Preparations: Better for dry nose, winter
- Preparations
- Flunisolide (Nasalide)
- Dose: 2 puffs in nose bid
- Relative potency: 3
- Fluticasone (Flonase)
- Dose: 2 puffs qd x1wk, then 1 puff qd
- Relative potency: 10
- Triamcinolone acetonide (Nasacort)
- Dose: 2 puffs qd for 1 week, then 1 puff per day
- Relative potency: 1
- Beclomethasone dipropionate (Beconase, Vancenase)
- Relative potency: 5
- Dose: 2 puffs bid (2 puffs qd for double strength)
- Budesonide (Rhinocort)
- Dose: 4 puffs qd for 1 week, then 2 puffs qd
- Relative potency: 10
- Flunisolide (Nasalide)
Flonase (C0286677) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C065382 |
| English | Flonase |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Beconase (C0591154) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) |
| MSH | C107432, D001507 |
| English | A & H Brand of Beclomethasone Dipropionate, Allen & Hanburys Brand of Beclomethasone Dipropionate, Becloforte, becodisk, Becodisks, Beconase, Becotide, Glaxo Wellcome Brand of Beclomethasone Dipropionate, GlaxoSmithKline Brand 1 of Beclomethasone Dipropionate, Propaderm, Sanasthmyl, Shire Brand of Beclomethasone Dipropionate |
| Sources | MSH, NCI, PDQ, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Nasacort (C0594040) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) |
| English | Nasacort |
| Sources | NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Rhinocort (C0678163) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) |
| MSH | D019819 |
| English | Rhinocort |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Vancenase (C0699072) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) |
| MSH | D001507 |
| English | Schering Brand 1 of Beclomethasone Dipropionate, Vancenase |
| Sources | MSH, NCI, PDQ, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Nasarel (C0721979) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) |
| MSH | C007734 |
| English | Elan Brand 2 of Flunisolide, Nasarel |
| Sources | MSH, MTH, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
